114 related articles for article (PubMed ID: 6814550)
1. Factor VIII-induced superaggregation of human platelets.
Kirby EP; Mills DC; Holmsen H; Russo M
Blood; 1982 Dec; 60(6):1359-69. PubMed ID: 6814550
[TBL] [Abstract][Full Text] [Related]
2. The interaction of bovine factor VIII with human platelets.
Kirby EP; Mills DC
J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
5. Adenine nucleotide metabolism during the aggregation of human platelets by bovine factor VIII.
Ostvold AC; Lindberg ME; Solum NO; Holmsen H
Haemostasis; 1975; 4(1):3-11. PubMed ID: 1193453
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
8. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
[TBL] [Abstract][Full Text] [Related]
9. Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function.
Levy-Toledano S; Tobelem G; Legrand C; Bredoux R; Degos L; Nurden A; Caen JP
Blood; 1978 Jun; 51(6):1065-71. PubMed ID: 647114
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
[TBL] [Abstract][Full Text] [Related]
11. Platelets from bleeding Simmental cattle mobilize calcium, phosphorylate myosin light chain and bind normal numbers of fibrinogen molecules but have abnormal cytoskeletal assembly and aggregation in response to ADP.
Searcy GP; Frojmovic MM; McNicol A; Robertson C; Wong T; Gerrard JM
Thromb Haemost; 1994 Feb; 71(2):240-6. PubMed ID: 8191406
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
14. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
15. Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets.
Suzuki H; Kinlough-Rathbone RL; Packham MA; Mustard JF; Tanoue K; Yamazaki H
J Histochem Cytochem; 1990 Jun; 38(6):869-74. PubMed ID: 2335742
[TBL] [Abstract][Full Text] [Related]
16. Adenine nucleotide metabolism of blood platelets. X. Formaldehyde stops centrifugation-induced secretion after A23187-stimulation and causes breakdown of metabolic ATP.
Holmsen H; Setkowsky Dangelmaier CA
Biochim Biophys Acta; 1977 Mar; 497(1):46-61. PubMed ID: 321037
[TBL] [Abstract][Full Text] [Related]
17. Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.
Kirby EP
Thromb Diath Haemorrh; 1975 Dec; 34(3):770-9. PubMed ID: 1239827
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
Puri RN; Colman RW
Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels.
Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
Blood; 1988 Apr; 71(4):850-60. PubMed ID: 2833330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
